IL-17 promotes osteoclast-induced bone loss by regulating glutamine-dependent energy metabolism
Renpeng Peng(Tongji Hospital), Feng Li(Tongji Hospital)
Cited by 42
Related Papers
FOXO1 inhibits osteosarcoma oncogenesis via Wnt/β-catenin pathway suppression
|Oncogenesis|2015|68
Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss
|Scientific Reports|2015|61
Urolithin A Inhibits the Catabolic Effect of TNFα on Nucleus Pulposus Cell and Alleviates Intervertebral Disc Degeneration in vivo
|Frontiers in Pharmacology|2018|53
Strontium-loaded titania nanotube arrays repress osteoclast differentiation through multiple signalling pathways: In vitro and in vivo studies
|Scientific Reports|2017|51
FOXO1 inhibits osteoclastogenesis partially by antagnozing MYC
|Scientific Reports|2015|38